{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T18:46:35Z","timestamp":1786387595656,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.pathol.2021.10.005","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T02:00:30Z","timestamp":1642816830000},"page":"425-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes"],"prefix":"10.1016","volume":"54","author":[{"given":"Michelle R.","family":"Downes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lajkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Kuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.10.005_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2021.10.005_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib4","series-title":"Histological Typing of Urinary Bladder Tumours","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.pathol.2021.10.005_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2021.10.005_bib6","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary and Male Genital Organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.pathol.2021.10.005_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib8","first-page":"1021","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.eururo.2009.09.022","article-title":"The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading","volume":"57","author":"van Rhijn","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib11","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.humpath.2012.01.008","article-title":"Histologic grading of urothelial carcinoma: a reappraisal","volume":"43","author":"Cheng","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2021.10.005_bib12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.euo.2020.12.002","article-title":"Prognostic value of the WHO1973 and WHO2004\/2016 classification systems for grade in primary Ta\/T1 non-muscle-invasive bladder cancer: a multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study","volume":"4","author":"van Rhijn","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.pathol.2021.10.005_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib14","article-title":"International Society of Urological Pathology expert opinion on grading of urothelial carcinoma","author":"van der Kwast","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.pathol.2021.10.005_bib15","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.5489\/cuaj.3320","article-title":"CUA guidelines on the management of non-muscle invasive bladder cancer","volume":"9","author":"Kassouf","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.pathol.2021.10.005_bib16","first-page":"557","article-title":"Immunohistochemical studies of the localization of prolactin in human term chorion laeve. (Japanese.)","volume":"68","author":"Satoh","year":"1992","journal-title":"Nihon Naibunpi Gakkai Zasshi"},{"key":"10.1016\/j.pathol.2021.10.005_bib17","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/j.clgc.2018.05.002","article-title":"Reproducibility and prognostic performance of the 1973 and 2004 World Health Organization classifications for grade in non-muscle-invasive bladder cancer: a multicenter study in 328 bladder tumors","volume":"16","author":"Bosschieter","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.pathol.2021.10.005_bib18","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2009.03.052","article-title":"Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications","volume":"57","author":"May","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083192","article-title":"Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder","volume":"9","author":"Mangrud","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2021.10.005_bib20","first-page":"1291","article-title":"Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder","volume":"169","author":"Bol","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pathol.2021.10.005_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00428-003-0905-0","article-title":"Reproducibility of the 1998 World Health Organization\/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder","volume":"443","author":"Yorukoglu","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2021.10.005_bib22","article-title":"The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2021.10.005_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bju.12666","article-title":"Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?","volume":"115","author":"Pellucchi","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.pathol.2021.10.005_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/modpathol.2014.154","article-title":"Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications","volume":"28","author":"van Rhijn","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2021.10.005_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ejso.2006.04.006","article-title":"Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma","volume":"32","author":"Kamel","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.pathol.2021.10.005_bib26","article-title":"Comparison between 1973 and 2004\/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder","author":"Colla Ruvolo","year":"2021","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2021.10.005_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351961","article-title":"Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?","volume":"92","author":"Gontero","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.pathol.2021.10.005_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-4295(02)01705-3","article-title":"Comparison of WHO\/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression","volume":"60","author":"Samaratunga","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.pathol.2021.10.005_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00345-020-03180-5","article-title":"Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up","volume":"39","author":"Mariappan","year":"2021","journal-title":"World J Urol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521005456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521005456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:28:28Z","timestamp":1758472108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521005456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0031302521005456"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.10.005","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}